NYSEARCA:PRTO RCN Pareto Strategic Allocation ETF (PRTO) Price, Holdings, & News $27.12 -0.07 (-0.26%) As of 07/31/2026 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatingsBuy This Stock About RCN Pareto Strategic Allocation ETF (NYSEARCA:PRTO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PRTO alerts:Sign Up Key Stats Today's Range$27.10▼$27.1850-Day Range N/A52-Week Range$24.68▼$28.16Volume340 shsAverage VolumeN/AMarket Capitalization$601.49 millionAssets Under ManagementN/ADividend YieldN/ANet Expense Ratio0.82%Aggregate RatingModerate Buy ETF Overview Proteon Therapeutics was a biopharmaceutical company focused on developing treatments for patients with kidney and vascular diseases. The company’s research and development efforts centered on therapies designed to address severe and life-threatening conditions, particularly those related to renal disease and vascular access for hemodialysis patients. One of Proteon Therapeutics’ best-known product candidates was vonapanitase, an investigational enzyme developed to improve vascular access outcomes in patients with end-stage renal disease who require hemodialysis. The company evaluated the therapy in clinical studies and worked to advance it through the regulatory process, although it did not establish a broad commercial product portfolio. Proteon Therapeutics was based in the United States and operated as a clinical-stage biotechnology company. Publicly available information on the company’s leadership changed over time, and the company is best known for its development-stage pipeline rather than a large marketed business.AI Generated. May Contain Errors. Read More RCN Pareto Strategic Allocation ETF ExpensesTypePRTOAsset Allocation ETFsMulti Asset ETFsNYSEARCA ETFsAll ETFsManagement Fee0.69%0.64%0.71%0.51%0.53%Other Expenses0.13%0.31%0.67%0.58%0.55%Total Expense0.82%0.86%1.16%0.74%0.73%Fee Waiver0.00%-0.17%-0.52%-0.70%-0.62%Net Expense0.82%0.80%0.97%0.58%0.60% Receive PRTO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for RCN Pareto Strategic Allocation ETF and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRTO ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com PRTO ETF - Frequently Asked Questions How have PRTO shares performed this year? RCN Pareto Strategic Allocation ETF's stock was trading at $27.56 on June 29, 2026. Since then, PRTO stock has decreased by 1.6% and is now trading at $27.12. How do I buy shares of RCN Pareto Strategic Allocation ETF? Shares of PRTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerTidal ETF Services Fund NameRCN Pareto Strategic Allocation ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:PRTO Inception Date3/25/2026 Fund ManagerNick Lumpp, Quinn Berry, Scott Snyder WebN/A PhoneN/AFund Focus Asset ClassMulti Asset BenchmarkN/A CategoryStrategy FocusAsset Allocation Development LevelBlended Development RegionGlobal Number of Holdings39 Fund Statistics Assets Under Management$0.00 Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorTidal ETF Services, LLC AdvisorTidal Investments, LLC CustodianU.S. Bank, N.A. DistributorForeside Fund Services, LLC Transfer AgentU.S. Bancorp Fund Services, LLC TrusteeN/A Lead Market MakerJane Street Miscellaneous Outstanding Shares22,179,000Beta0.60 Creation Fee$300.00 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report Top 10 PRTO HoldingsiShares Russell 2000 ETF (NYSEARCA:IWM)Holding Weight: 21.75%Schwab US Small-Cap ETF (NYSEARCA:SCHA)Holding Weight: 21.72%abrdn Physical Gold Shares ETF (NYSEARCA:SGOL)Holding Weight: 11.88%Invesco QQQ (NASDAQ:QQQ)Holding Weight: 7.72%State Street® SPDR® S&P 500® ETFHolding Weight: 7.68%SPDR Gold MiniShares Trust (NYSEARCA:GLDM)Holding Weight: 6.63%Schwab US Dividend Equity ETF (NYSEARCA:SCHD)Holding Weight: 5.18%Simplify Managed Futures Strategy ETF (NYSEARCA:CTA)Holding Weight: 3.62%Vanguard Total International Stock ETF (NASDAQ:VXUS)Holding Weight: 2.50%Technology Select Sector SPDR Fund (NYSEARCA:XLK)Holding Weight: 2.49%Full Holdings DetailsPRTO Sector ExposurePRTO Industry Exposure This page (NYSEARCA:PRTO) was last updated on 8/1/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredBofA: Digital Dollar Coming 2025-2030Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredElon's new "super startup"Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RCN Pareto Strategic Allocation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share RCN Pareto Strategic Allocation ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
